Immunotherapy involves understanding and harnessing the relationship between the immune system and cancer cells to combat oncogenesis. There are many different potential immunotherapeutic approaches, including cell-based strategies such as adoptive cell transfer, receptor pathway-based strategies such as checkpoint inhibition, and agent-based approaches such as antibody therapy. Genetic engineering can be incorporated into all of these approaches. Gene editing can be used to modulate receptor expression levels, induce the production of certain molecules, change cellular phenotypes, or alter the general intensity of the immune response.
Cell volume is an important indicator of white blood cell health and therapeutic potentialRich Jones, Ph.D., gave a talk at Phacilitate Leaders Summit and World Stem Cell Summit titled "Cell volume is an important indicator of white blood cell health and therapeutic potential". Dr. Jones compares 3 technologies for determining cell volume, flow cytometry, cell imaging, and the Coulter method.